Molecular Genetic Evidence for Monoclonal Origin of Bilateral Ovarian Serous Borderline Tumors
- 1 April 2003
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 162 (4) , 1095-1101
- https://doi.org/10.1016/s0002-9440(10)63906-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomasInternational Journal of Cancer, 2002
- Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicityCancer, 2002
- Molecular Genetic Evidence for Different Clonal Origin of Components of Human Renal AngiomyolipomasThe American Journal of Surgical Pathology, 2001
- PCR artifacts in LOH and MSI analysis of microdissected tumor cellsHuman Pathology, 2000
- Comparison of allelic ratios from paired blood and paraffin-embedded normal tissue for use in a polymerase chain reaction to assess loss of heterozygosity2Molecular Diagnosis, 1999
- Microsatellite alterations as clonal markers for the detection of human cancer.Proceedings of the National Academy of Sciences, 1994
- Clonal Origin of Epithelial Ovarian Carcinoma: Analysis by Loss of Heterozygosity, p53 Mutation, and X-Chromosome InactivationJNCI Journal of the National Cancer Institute, 1992
- Ovarian Serous Tumors of Low Malignant Potential (Serous Borderline Tumors) The Relationship of Exophytic Surface Tumor to Peritoneal “Implants”The American Journal of Surgical Pathology, 1992
- X‐chromosome inactivation patterns using HPRT and PGK polymorphisms in haematologically normal and post‐chemotherapy femalesBritish Journal of Haematology, 1991
- X‐CHROMOSOME INACTIVATION AND DEVELOPMENTAL PATTERNS IN MAMMALSBiological Reviews, 1972